Neurobeachin-Like 1 (NBEAL1) Peptide
-
- Target See all NBEAL1 products
- NBEAL1 (Neurobeachin-Like 1 (NBEAL1))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- KDNDKNMSTE DTKKNSDEKT DEEKITSFAS ANVSSDQWSL EDRHSLDSNT
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of NBEAL1 antibody,
Alternative Names: NBEAL1 control peptide, NBEAL1 antibody Blocking Peptide, Anti-NBEAL1 Blocking Peptide, Neurobeachin-Like 1 Blocking Peptide, A530083I02Rik Blocking Peptide, ALS2CR17 Blocking Peptide, NBEAL1, NBEAL-1, NBEAL 1, NBEAL-1 Blocking Peptide, NBEAL 1 Blocking Peptide - Purification
- The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- NBEAL1 (Neurobeachin-Like 1 (NBEAL1))
- Background
- NBEAL1 belongs to the WD repeat neurobeachin family. It contains 1 BEACH domain and 2 WD repeats. NBEAL1 is highly expressed in brain, kidney, prostate and testis and weakly expressed in ovary, small intestine, colon and peripheral blood leukocytes. It may be correlative to several tumors, such as ovary serous adenocarcinoma and metastasis mammary gland carcinoma breast.
- Molecular Weight
- 153 kDa
-